A Study of CCX140-B in Subjects With FSGS

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 17, 2018

Primary Completion Date

February 19, 2020

Study Completion Date

February 19, 2020

Conditions
FSGSFocal Segmental GlomerulosclerosisGlomerulosclerosis
Interventions
OTHER

Placebo

Three placebo tablets, taken twice daily (BID), per os, for 84 days (12 weeks)

DRUG

CCX140-B

One 5 mg CCX140-B tablet and 2 placebo tablets in the morning; 3 placebo tablets in the evening; per os, for 84 days.

DRUG

CCX140-B

Two 5 mg CCX140-B tablets and 1 placebo tablet, taken BID; per os, for 84 days.

DRUG

CCX140-B

Three 5 mg CCX140-B tablets, taken BID; per os, for 84 days.

Trial Locations (37)

3084

Austin Health, Heidelberg

3168

Monash Medical Centre, Clayton

4310

Taranaki Base Hospital, New Plymouth

13385

APHM - Hopital de la Conception, Marseille

16132

IRCCS Azienda Ospedaliera Universitaria San Martino IST, Genova

24127

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo

25018

Presidio Ospedaliero di Montichiari-A.O. Spedali Civili di Brescia, Montichiari

27100

Fondazione S. Maugeri IRCCS, Pavia

27834

East Carolina University, Greenville

33076

CHU Bordeaux- Hospital Pellegrin, Bordeaux

38043

CHU de Grenoble, Grenoble

55414

University of Minnesota, Minneapolis

57045

Hopitaux Prives de Metz, Metz

71101

Northwest Louisiana Nephrology, Shreveport

77030

University of Texas Health Sciences Center, Houston

84115

Utah Kidney Research Institute, Salt Lake City

85016

AKDHC, Phoenix

90502

Los Angeles Biomedical Research Institute, Torrance

94010

CHU Henri Mondor, Créteil

02114

MGH, Boston

02903

Rhode Island Hospital, Providence

Unknown

Royal Melbourne Hospital, Parkville

SCM Sp. Zo.o., Krakow

Samodzielny Publiczny Zaklad Opieki Zdrowotnez Centralny Szpital, Lodz

Samodzielny Publiczny Szpital Kliniczny, Szczecin

L8N4A6

St. Josephs Healthcare - Hamilton, Hamilton

M4G 3E8

Sunnybrook Health Sciences Centre (Odette Cancer Center), Toronto

M5G2C4

Toronto General Hospital, Toronto

J4V2H1

CISSS de la Monteregie-Centre - Hopital Charles LeMoyne, Greenfield Park

00168

Fondazione Policlinico Universitario A. Gemelli - Universita Cattolica del Sacro Cuore, Rome

0622

North Shore Hospital, Takapuna

15-276

Uniwersytecki Szpital Kliniczny w Bialymstoku - II Klinika Nefrologii z Oddzialem Leczenia Nadcisnienia Tetniczego i Pododdzialem Dializoterapii, Bialystok

50-556

Uniwersytecki Szpital Kliniczny Klinika Nefrologii i Medycyny Transplantacyjnej, Wroclaw

CB2 0OQ

Cambridge University - Addenbrooke's Hospital, Cambridge

CF14 4XW

University Hospital of Wales, Cardiff

M6 8HD

Salford Royal NHS Foundation Trust Manchester, Salford

SA6 6NL

Morriston Hospital, Swansea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT03536754 - A Study of CCX140-B in Subjects With FSGS | Biotech Hunter | Biotech Hunter